These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 28498180)

  • 1. Beyond "Option B+": Understanding Antiretroviral Therapy (ART) Adherence, Retention in Care and Engagement in ART Services Among Pregnant and Postpartum Women Initiating Therapy in Sub-Saharan Africa.
    Myer L; Phillips TK
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S115-S122. PubMed ID: 28498180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of postpartum healthcare services for HIV-infected women and their infants in South Africa: A randomised controlled trial.
    Myer L; Phillips TK; Zerbe A; Brittain K; Lesosky M; Hsiao NY; Remien RH; Mellins CA; McIntyre JA; Abrams EJ
    PLoS Med; 2018 Mar; 15(3):e1002547. PubMed ID: 29601570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of suboptimal adherence and elevated HIV viral load in pregnant women already on antiretroviral therapy when entering antenatal care in Cape Town, South Africa.
    Brittain K; Remien RH; Mellins CA; Phillips TK; Zerbe A; Abrams EJ; Myer L
    AIDS Care; 2018 Dec; 30(12):1517-1523. PubMed ID: 30047287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shifting to the long view: engagement of pregnant and postpartum women living with HIV in lifelong antiretroviral therapy services.
    Phillips TK; Myer L
    Expert Rev Anti Infect Ther; 2019 May; 17(5):349-361. PubMed ID: 30978126
    [No Abstract]   [Full Text] [Related]  

  • 5. Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review.
    Omonaiye O; Kusljic S; Nicholson P; Manias E
    BMC Public Health; 2018 Jun; 18(1):805. PubMed ID: 29945601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'I wanted to safeguard the baby': a qualitative study to understand the experiences of Option B+ for pregnant women and the potential implications for 'test-and-treat' in four sub-Saharan African settings.
    McLean E; Renju J; Wamoyi J; Bukenya D; Ddaaki W; Church K; Zaba B; Wringe A
    Sex Transm Infect; 2017 Jul; 93(Suppl 3):. PubMed ID: 28736391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cohort profile: the Hlabisa pregnancy cohort, KwaZulu-Natal, South Africa.
    Chetty T; Thorne C; Tanser F; Bärnighausen T; Coutsoudis A
    BMJ Open; 2016 Oct; 6(10):e012088. PubMed ID: 27798004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study.
    Katirayi L; Namadingo H; Phiri M; Bobrow EA; Ahimbisibwe A; Berhan AY; Buono N; Moland KM; Tylleskär T
    J Int AIDS Soc; 2016; 19(1):20919. PubMed ID: 27312984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of individual and contextual factors affecting ART initiation, adherence, and retention for HIV-infected pregnant and postpartum women.
    Hodgson I; Plummer ML; Konopka SN; Colvin CJ; Jonas E; Albertini J; Amzel A; Fogg KP
    PLoS One; 2014; 9(11):e111421. PubMed ID: 25372479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Same-day antiretroviral therapy (ART) initiation in pregnancy is not associated with viral suppression or engagement in care: A cohort study.
    Langwenya N; Phillips TK; Brittain K; Zerbe A; Abrams EJ; Myer L
    J Int AIDS Soc; 2018 Jun; 21(6):e25133. PubMed ID: 29939483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of pregnancy, postpartum risk of virologic failure and loss to follow-up among HIV-positive women.
    Onoya D; Sineke T; Brennan AT; Long L; Fox MP
    AIDS; 2017 Jul; 31(11):1593-1602. PubMed ID: 28463877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to antiretroviral treatment among pregnant and postpartum HIV-infected women.
    Mellins CA; Chu C; Malee K; Allison S; Smith R; Harris L; Higgins A; Zorrilla C; Landesman S; Serchuck L; Larussa P
    AIDS Care; 2008 Sep; 20(8):958-68. PubMed ID: 18608073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of HIV Care Clinic Attendance and Adherence to Antiretroviral Therapy Among Pregnant and Breastfeeding Women Living With HIV in the Context of Option B+ in Zimbabwe.
    Erlwanger AS; Joseph J; Gotora T; Muzunze B; Orne-Gliemann J; Mukungunugwa S; Farley T; Mangwiro AZ
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S198-S206. PubMed ID: 28498190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiated models of care for postpartum women on antiretroviral therapy in Cape Town, South Africa: a cohort study.
    Myer L; Iyun V; Zerbe A; Phillips TK; Brittain K; Mukonda E; Allerton J; Kalombo CD; Nofemela A; Abrams EJ
    J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21636. PubMed ID: 28770593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-based adherence clubs for postpartum women on antiretroviral therapy (ART) in Cape Town, South Africa: a pilot study.
    Zerbe A; Brittain K; Phillips TK; Iyun VO; Allerton J; Nofemela A; Kalombo CD; Myer L; Abrams EJ
    BMC Health Serv Res; 2020 Jul; 20(1):621. PubMed ID: 32641032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing Antiretroviral Therapy (ART) for Maternal and Child Health (MCH): Rationale and Design of the MCH-ART Study.
    Myer L; Phillips TK; Zerbe A; Ronan A; Hsiao NY; Mellins CA; Remien RH; Le Roux SM; Brittain K; Ciaranello A; Petro G; McIntyre JA; Abrams EJ
    J Acquir Immune Defic Syndr; 2016 Aug; 72 Suppl 2(Suppl 2):S189-96. PubMed ID: 27355508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attitudes Toward Long-Term Use of Antiretroviral Therapy Among HIV-Infected Pregnant Women in Moshi, Tanzania: A Longitudinal Study.
    Minja L; Cichowitz C; Knettel BA; Mahande MJ; Kisigo G; Knippler ET; Ngocho JS; Mmbaga BT; Watt MH
    AIDS Behav; 2019 Sep; 23(9):2610-2617. PubMed ID: 31377894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal Motivation to Take Preventive Therapy in Antepartum and Postpartum Among HIV-Positive Pregnant Women in South Africa: A Choice Experiment.
    Kim HY; Dowdy DW; Martinson NA; Kerrigan D; Tudor C; Golub J; Bridges JFP; Hanrahan CF
    AIDS Behav; 2019 Jul; 23(7):1689-1697. PubMed ID: 30415430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disengagement of HIV-positive pregnant and postpartum women from antiretroviral therapy services: a cohort study.
    Phillips T; Thebus E; Bekker LG; Mcintyre J; Abrams EJ; Myer L
    J Int AIDS Soc; 2014; 17(1):19242. PubMed ID: 25301494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experiences of HIV-positive postpartum women and health workers involved with community-based antiretroviral therapy adherence clubs in Cape Town, South Africa.
    Trafford Z; Gomba Y; Colvin CJ; Iyun VO; Phillips TK; Brittain K; Myer L; Abrams EJ; Zerbe A
    BMC Public Health; 2018 Jul; 18(1):935. PubMed ID: 30064405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.